beta

AGTC

Applied Genetic Technologies Corporation

Agtc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Applied Genetic Technologies Corp is a clinical-stage biotechnology company focused on gene therapy through a nontoxic adeno-associated virus. The company also offers products such as promoters, expression cassettes, and capsids for gene therapy.

Market Cap: 85 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.agtc.com

Shares Outstanding: 18.1 Million

Float: 18 Million

Dividend: 0.0 (0.0%)

Beta: 1.941939

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 217 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1858 trading days

From: 2014-06-18 To: 2019-10-18

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud